New CEO of Swedish Operations Announced by Kemwell AB - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

New CEO of Swedish Operations Announced by Kemwell AB

8th September 2014

Kemwell AB, part of the Kemwell group, which is a contract pharmaceutical development and manufacturing company with facilities in Sweden, India and the US, has announced the appointment of Mikael Ericson as the new CEO of its Swedish operations.

Mikael assumed responsibilities on 1 September 2014, and will succeed Agneta Bergvall. Mikael Ericson is highly experienced in production, logistics and lean management. He has held various international management positions in large corporations in both pharmaceutical and automotive industries, such as AstraZeneca, Scania and Plastal Industri with success.

He has achieved great productivity improvements year on year by introducing lean ways of working and engaging people in process development and continuous improvements while always maintaining a strong focus on the customer.

"With his in-depth technical and business background, Mikael will be an excellent leader for taking the company to the next level together along with Kemwell’s experienced associates," said the chairman of the board, PerAke Oldentoft.

More About This Company